2019
Overall survival is improved when DCIS accompanies invasive breast cancer
Kole AJ, Park HS, Johnson SB, Kelly JR, Moran MS, Patel AA. Overall survival is improved when DCIS accompanies invasive breast cancer. Scientific Reports 2019, 9: 9934. PMID: 31289308, PMCID: PMC6616329, DOI: 10.1038/s41598-019-46309-2.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAged, 80 and overBiomarkers, TumorBreast NeoplasmsCarcinoma, Ductal, BreastCarcinoma, Intraductal, NoninfiltratingCarcinoma, LobularCombined Modality TherapyFemaleFollow-Up StudiesHumansMiddle AgedNeoplasm InvasivenessPrognosisReceptor, ErbB-2Receptors, EstrogenReceptors, ProgesteroneRetrospective StudiesSurvival RateConceptsInvasive ductal carcinomaOverall survivalDCIS componentDuctal carcinomaBreast cancerER/PR positivityPure invasive ductal carcinomasMultivariable Cox modelingReceipt of mastectomyNational Cancer DatabaseSuperior overall survivalNode-negative diseaseBetter overall survivalInvasive breast cancerFavorable clinical characteristicsTreatment-related variablesUseful prognostic factorBreast cancer patientsInvasive tumor sizeDifferent biological behaviorPR positivityClinical characteristicsNegative diseaseCox modelingPrognostic factors
2016
Association between access to accelerated partial breast irradiation and use of adjuvant radiotherapy
Wang EH, Park HS, Rutter CE, Gross CP, Soulos PR, Yu JB, Evans SB. Association between access to accelerated partial breast irradiation and use of adjuvant radiotherapy. Cancer 2016, 123: 502-511. PMID: 27657353, DOI: 10.1002/cncr.30356.Peer-Reviewed Original ResearchConceptsBreast-conserving surgeryInvasive cancerDuctal carcinomaNational Cancer Data BaseEarly-stage breast cancerReceipt of radiotherapySubgroup multivariable analysisSubset of patientsMultivariable logistic regressionPartial breast irradiationOverall sampleRT receiptAdjuvant radiotherapyEligible patientsRT useMultivariable analysisRetrospective studyBreast irradiationBreast cancerIndependent factorsPatientsRadiotherapyCancerLogistic regressionAPBI
2015
Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation Surgery
An Y, Rutter C, Park H, Corso C, Mancini B, Lester-Coll N, Yeboa D, Evans S. Adoption of Hypofractionated Whole-Breast Irradiation for Ductal Carcinoma In Situ Patients After Breast Conservation Surgery. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e54-e55. DOI: 10.1016/j.ijrobp.2015.07.680.Peer-Reviewed Original ResearchIncreasing Use of Post Lumpectomy Radiation Therapy for Ductal Carcinoma In Situ of the Breast in the United States
An Y, Rutter C, Park H, Stahl J, Corso C, Mancini B, Lester-Coll N, Yeboa D, Evans S. Increasing Use of Post Lumpectomy Radiation Therapy for Ductal Carcinoma In Situ of the Breast in the United States. International Journal Of Radiation Oncology • Biology • Physics 2015, 93: e50. DOI: 10.1016/j.ijrobp.2015.07.669.Peer-Reviewed Original ResearchGrowing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States
Rutter CE, Park HS, Killelea BK, Evans SB. Growing Use of Mastectomy for Ductal Carcinoma-In Situ of the Breast Among Young Women in the United States. Annals Of Surgical Oncology 2015, 22: 2378-2386. PMID: 25564175, DOI: 10.1245/s10434-014-4334-x.Peer-Reviewed Original ResearchConceptsContralateral prophylactic mastectomyUse of mastectomyYounger patientsHigh-risk histopathologic featuresNational Cancer Data BaseGreater medical comorbidityRate of mastectomyYounger patient ageBreast conservation therapyMultivariable logistic regressionHigh tumor gradeProportion of womenBackgroundDuctal carcinomaPreinvasive formExtensive diseaseMastectomy ratesMedical comorbiditiesPatient ageConservation therapyDuctal carcinomaHistopathologic featuresExcellent outcomesProphylactic mastectomySurgical choiceTumor grade